肿瘤防治研究2009，Vol.36Issue(11)：928-931,4.DOI:10.3971/j.issn.1000-8578.2009.11.008
酶联免疫斑点法检测鼻咽癌患者放疗前后T细胞对EB病毒肽段的特异性反应
ELISPOT Assay to Detect Specific Reaction of T Cells to EBV Peptide Segments for Patients with Nasopharyngeal Carcinoma before and after Radiotherapy
王若峥 1谭遥 1王多明 1黄莉 1李晓霞1
作者信息
- 1. 830011,乌鲁木齐,新疆医科大学附属肿瘤医院放一科
- 折叠
摘要
Abstract
Objective To investigate the change of specific immunoreaction of T cells before and after radiotherapy in the patients with nasopharyngeal carcinoma,and to search the factors correlated to the curative effect. Methods Forty-one nasopharyngeal carcinoma patients were investigated in the study. 10 ml blood were taken before and 3 months after the radiotherapy, PBMCs were separated and specific responses T cell to EBV peptide segments such as peptide, LMP1, LMP2, EBNA1 and EBNA3 were measured by using ELISPOT assay. Results We found that,after radiotherapy, there are 36 cases of CR,4 cases of PR, 1 case of PD, whose frequency of CTL cells in peripheral blood response to LMP1 significantly increased(P=0.004),while had no statistical significance in the respone to LMP2、EBNA1 and EBNA3.The frequency of CTL cells in the groups with different curative effect responsed to LMP1 also had statistical significance. Conclusion ELISPOT assay can be used to detect the specific responses of T cell to LMP1 before and after radiotherapy in the patients with nasopharyngeal carcinoma. This provides basic data for the development of potential therapy in combination of immuno-and radiotherapy, as well as for the evaluation of the treatment to these patients.关键词
鼻咽癌/放射治疗/酶联免疫斑点法Key words
Nasopharyngeal carcinoma/ Radiotherapy/ Enzyme link immunal spot分类
医药卫生引用本文复制引用
王若峥,谭遥,王多明,黄莉,李晓霞..酶联免疫斑点法检测鼻咽癌患者放疗前后T细胞对EB病毒肽段的特异性反应[J].肿瘤防治研究,2009,36(11):928-931,4.
